Rhythm: Navigating Imcivree's Potential In Rare Obesity Treatments (Rating Upgrade)
Rhythm Pharmaceuticals, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $87.87
+7.1% in 7d after detection
Post-detection moves
1h
—
1d
+0.4%
3d
+3.9%
7d
+7.1%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS